ArticleJournal of thoracic disease2025
Analysis of the effect of Preset Cabrol in total arch replacement for type A aortic dissection.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between Cabrol shunt and new-onset atrial fibrillation after acute type A aortic dissection surgery: a retrospective study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hemostasis can be challenging after ascending aorta replacement and Sun's procedure. This study aims to assess the impact of employing the Preset Cabrol technique during these procedures. Methods: A retrospective analysis was conducted on 258 consecutive patients diagnosed with type A aortic dissection (TAAD) who underwent ascending aortic replacement and Sun's procedure between January 2021 and January 2024. The patients were divided into two groups: the preset group (n=203) and the control group (n=55). Results: There were no significant differences between the groups in terms of 30-day mortality (preset: 6.9% Conclusions: The Preset Cabrol technique is proven to be a valuable tool during ascending aortic replacement and Sun's procedure. It effectively controls bleeding, leading to reduced CPB and operation times, decreased blood product transfusion, and lower hospitalization costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.